Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins

Area of Science:

• Proteomics and Cancer Research
• Molecular Biology
• Biotechnology

Background:

• DNA microarray technology has advanced cancer molecular classification.
• Global protein profiling in cancer cells presents significant challenges.
• A need exists for high-throughput methods to analyze protein expression in complex biological samples.

Purpose of the Study:

• To describe a novel microarray-based platform for measuring protein levels and activities.
• To investigate alterations in protein expression in colon carcinoma cells following ionizing radiation treatment.
• To explore the utility of protein microarrays in high-throughput proteomic studies of cancer.

Main Methods:

• Development and application of a protein microarray platform with 1920 elements (146 distinct antibodies).
• Analysis of protein level alterations in LoVo colon carcinoma cells treated with ionizing radiation.
• Validation of selected microarray findings using traditional immunoblotting techniques.

Main Results:

• The protein microarray identified radiation-induced up-regulation of key apoptotic regulators, including p53 and caspase-activated DNase pathway components.
• An increased percentage of apoptosis was observed in irradiated LoVo cells, consistent with the proteomic data.
• Radiation treatment led to the down-regulation of carcinoembryonic antigen, a known cancer biomarker.

Conclusions:

• Protein/antibody microarrays provide a powerful tool for high-throughput proteomic analysis in cancer research.
• This technology facilitates the monitoring of protein expression changes in response to therapeutic interventions like radiation.
• The findings contribute to a better understanding of molecular mechanisms underlying cancer and carcinogenesis.